Position in DGX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$25,629,676
+$11,852,262 QoQ
Shares Held
130,777
+64.7% QoQ
Ownership
0.118%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in DGX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Gotham Asset Management, LLC holds $408,638,021 across 19 Diagnostics & Research names. DGX ranks #6 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRL |
Charles River Laboratories International, Inc.
|
358,502 | $61,841,595 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
102,065 | $50,168,009 | |
| 3 | LH |
Labcorp Holdings Inc.
|
182,216 | $48,617,050 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
80,477 | $45,219,221 | |
| 5 | ILMN |
Illumina, Inc.
|
341,936 | $42,147,031 | |
| 6 | DGX |
Quest Diagnostics Inc
This page
|
130,777 | $25,629,676 | |
| 7 | WAT |
Waters Corp /De/
|
71,515 | $21,297,167 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
111,419 | $19,001,396 |
All Filings in DGX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $25,629,676 | 130,777 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $13,777,414 | 79,395 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $10,423,582 | 54,694 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,355,309 | 29,813 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,570,852 | 9,284 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $202,303 | 1,341 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $289,696 | 1,866 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $923,255 | 6,745 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,417,144 | 18,159 | Shares | Sole | 2024-05-15 | |
| 2023-03-31 | $281,545 | 1,990 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,706,220 | 23,691 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,529,622 | 20,618 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,846,047 | 28,922 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $4,454,108 | 32,545 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $4,111,236 | 23,763 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $4,903,631 | 33,746 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,367,409 | 17,939 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $3,346,722 | 26,077 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $6,451,387 | 54,136 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,254,008 | 10,953 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,424,500 | 12,500 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $7,626,091 | 94,970 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||